
Academic Journal
Q2Pulmonary Circulation
About Pulmonary Circulation
Pulmonary Circulation is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q2, with an SJR of 0.762 and H-index of 63.
Coverage: 2011-2026. Research categories: Pulmonary and Respiratory Medicine (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Pulmonary Hypertension Research and Treatments; Cardiovascular Function and Risk Factors; Heart Failure Treatment and Management; Cardiovascular Issues in Pregnancy; Vascular Anomalies and Treatments; Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
EXPRESS: Particulate Matter Disrupts Human Lung Endothelial Cell Barrier Integrity via Rho-dependent Pathways
Ting Wang, Yuka Shimizu, Xiaomin Wu, Gabriel T. Kelly et al.
2017-06-08 · DOI: 10.1177/2045893217717218Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension
C. Schreiber, M.S. Eilenberg, A. Panzenboeck, M.P. Winter et al.
2017-03-13 · DOI: 10.1177/2045893216677519Pulmonary Extra-medullary Hematopoiesis and Pulmonary Hypertension From Underlying Polycythemia Vera: A Case Series.
Inderjit Singh, Geoffrey Mikita, Daniel Benjamin Green, Cristobal Risquez et al.
2016-12-14 · DOI: 10.1086/690730Pulmonary hypertension's variegated landscape: a snapshot
Thomas J. Kulik, Eric D. Austin
2016-12-02 · DOI: 10.1086/690552Do Single or Sequential Measurements of Leptin and Adiponectin in Plasma Have Prognostic Value in Pulmonary Arterial Hypertension?
Adriano Tonelli, Wassim Fares, Wael Dakkak, Youlan Rao et al.
2016-10-17 · DOI: 10.1086/689907A High-yield Isolation and Enrichment Strategy for Human Lung Microvascular Endothelial Cells
Christa Gaskill, Susan Majka
2016-10-13 · DOI: 10.1086/689759Masthead
2016-06 · DOI: 10.1086/687515Reviews
Community Reviews
Version History
October 4, 2026 at 9:06 pm
October 2, 2026